Related references
Note: Only part of the references are listed.Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications
Chao Tao et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
A novel purification procedure for recombinant human serum albumin expressed in Pichia pastoris
Shijie Li et al.
PROTEIN EXPRESSION AND PURIFICATION (2018)
A long-acting PAI-1 inhibitor reduces thrombus formation
Shuangzhou Peng et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy
Zhibo Liu et al.
CHEMICAL SOCIETY REVIEWS (2016)
A New Class of Orthosteric uPAR•uPA Small-Molecule Antagonists Are Allosteric Inhibitors of the uPAR•Vitronectin Interaction
Degang Liu et al.
ACS CHEMICAL BIOLOGY (2015)
A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging
Xiaolei Zhou et al.
ACTA BIOMATERIALIA (2015)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide-Protease Fusions
Hans Peter Sorensen et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Enhancement of recombinant human serum albumin in transgenic rice cell culture system by cultivation strategy
Yu-Kuo Liu et al.
New Biotechnology (2015)
Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability
Miriam Dadparvar et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
A Novel Tumor Targeting Drug Carrier for Optical Imaging and Therapy
Rui Li et al.
THERANOSTICS (2014)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes
Yong-Mo Kim et al.
BMB REPORTS (2013)
The Future of Peptide-based Drugs
David J. Craik et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
Craig Giragossian et al.
CURRENT DRUG METABOLISM (2013)
Structural Mechanism of Ring-opening Reaction of Glucose by Human Serum Albumin
Yu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
Michael M. Schmidt et al.
STRUCTURE (2013)
The homogeneous fluorescence anisotropic sensing of salivary lysozyme using the 6-carboxyfluorescein-labeled DNA aptamer
Mingjian Zou et al.
BIOSENSORS & BIOELECTRONICS (2012)
Impact of albumin on drug delivery - New applications on the horizon
Bakheet Elsadek et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Human serum albumin: From bench to bedside
Gabriella Fanali et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
Jan Terje Andersen et al.
NATURE COMMUNICATIONS (2012)
Large-scale production of functional human serum albumin from transgenic rice seeds
Yang He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Spectroscopic and molecular modeling evidence of clozapine binding to human serum albumin at subdomain IIA
Xinhu Wu et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2011)
Structural basis of transport of lysophospholipids by human serum albumin
Shihui Guo et al.
BIOCHEMICAL JOURNAL (2009)
Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
Kristi Baker et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Genetic fusion to albumin improves the pharmacokinetic properties of factor IX
Hubert J. Metzner et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Prolonged in-vivo half-life of factor VIIa by fusion to albumin
Thomas Weimer et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin
Dafne Mueller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin
Feng Yang et al.
JOURNAL OF STRUCTURAL BIOLOGY (2007)
Summary of recombinant human serum albumin development
K Kobayashi
BIOLOGICALS (2006)
Structure of human urokinase plasminogen activator in complex with its receptor
Q Huai et al.
SCIENCE (2006)
Production of human serum albumin by sugar starvation induced promoter and rice cell culture
LF Huang et al.
TRANSGENIC RESEARCH (2005)
Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143)
MD Huang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2005)
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide
P Llinas et al.
EMBO JOURNAL (2005)
The urokinase receptor as a potential target in cancer therapy
J Romer et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements
LH Lucas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics
N Schmiedeberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)
V Magdolen et al.
BIOLOGICAL CHEMISTRY (2001)
Share Paper
